Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 381

1.

A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders.

Schimmelmann BG, Mehler-Wex C, Lambert M, Schulze-zur-Wiesch C, Koch E, Flechtner HH, Gierow B, Maier J, Meyer E, Schulte-Markwort M.

J Child Adolesc Psychopharmacol. 2007 Dec;17(6):768-78. doi: 10.1089/cap.2007.0048.

PMID:
18315449
[PubMed - indexed for MEDLINE]
2.

Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.

Zhong KX, Sweitzer DE, Hamer RM, Lieberman JA.

J Clin Psychiatry. 2006 Jul;67(7):1093-103.

PMID:
16889453
[PubMed - indexed for MEDLINE]
3.

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.

Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG.

Arch Gen Psychiatry. 1997 Jun;54(6):549-57.

PMID:
9193196
[PubMed - indexed for MEDLINE]
4.

A comparative pilot study of second-generation antipsychotics in children and adolescents with schizophrenia-spectrum disorders.

Jensen JB, Kumra S, Leitten W, Oberstar J, Anjum A, White T, Wozniak J, Lee SS, Schulz SC.

J Child Adolesc Psychopharmacol. 2008 Aug;18(4):317-26. doi: 10.1089/cap.2007.0123.

PMID:
18759641
[PubMed - indexed for MEDLINE]
5.

[Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].

György B, Robert K, László C, Andrea J; Ketilept Vizsgáló Munkacsoport.

Neuropsychopharmacol Hung. 2008 Dec;10(5):293-303. Hungarian.

PMID:
19419015
[PubMed - indexed for MEDLINE]
Free Article
6.

Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.

Findling RL, McKenna K, Earley WR, Stankowski J, Pathak S.

J Child Adolesc Psychopharmacol. 2012 Oct;22(5):327-42. doi: 10.1089/cap.2011.0092.

PMID:
23083020
[PubMed - indexed for MEDLINE]
7.

Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):360-70. Epub 2007 Jul 14.

PMID:
17629731
[PubMed - indexed for MEDLINE]
8.

Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.

Buckley PF.

Curr Med Res Opin. 2004 Sep;20(9):1357-63.

PMID:
15383183
[PubMed - indexed for MEDLINE]
9.

[An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia].

Beszłej JA, Grzesiak M.

Psychiatr Pol. 2005 Mar-Apr;39(2):293-307. Polish.

PMID:
15881624
[PubMed - indexed for MEDLINE]
10.

Effectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: an open-label study.

Zalsman G, Carmon E, Martin A, Bensason D, Weizman A, Tyano S.

J Child Adolesc Psychopharmacol. 2003 Fall;13(3):319-27.

PMID:
14642020
[PubMed - indexed for MEDLINE]
11.

Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.

Lee KU, Jeon YW, Lee HK, Jun TY.

Hum Psychopharmacol. 2009 Aug;24(6):447-52. doi: 10.1002/hup.1047.

PMID:
19606454
[PubMed - indexed for MEDLINE]
12.

Long-Term use of quetiapine in elderly patients with psychotic disorders.

Tariot PN, Salzman C, Yeung PP, Pultz J, Rak IW.

Clin Ther. 2000 Sep;22(9):1068-84.

PMID:
11048905
[PubMed - indexed for MEDLINE]
13.

Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.

McConville BJ, Arvanitis LA, Thyrum PT, Yeh C, Wilkinson LA, Chaney RO, Foster KD, Sorter MT, Friedman LM, Brown KL, Heubi JE.

J Clin Psychiatry. 2000 Apr;61(4):252-60.

PMID:
10830145
[PubMed - indexed for MEDLINE]
14.

Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label study.

Dittmann RW, Meyer E, Freisleder FJ, Remschmidt H, Mehler-Wex C, Junghanss J, Hagenah U, Schulte-Markwort M, Poustka F, Schmidt MH, Schulz E, Mästele A, Wehmeier PM.

J Child Adolesc Psychopharmacol. 2008 Feb;18(1):54-69. doi: 10.1089/cap.2006.0137.

PMID:
18294089
[PubMed - indexed for MEDLINE]
15.

Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial.

Sacchetti E, Panariello A, Regini C, Valsecchi P.

Schizophr Res. 2004 Aug 1;69(2-3):325-31.

PMID:
15469204
[PubMed - indexed for MEDLINE]
16.

Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.

Canuso CM, Dirks B, Carothers J, Kosik-Gonzalez C, Bossie CA, Zhu Y, Damaraju CV, Kalali AH, Mahmoud R.

Am J Psychiatry. 2009 Jun;166(6):691-701. doi: 10.1176/appi.ajp.2009.08040613. Epub 2009 May 1.

PMID:
19411369
[PubMed - indexed for MEDLINE]
17.

Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.

Westheide J, Cvetanovska G, Albrecht C, Bliesener N, Cooper-Mahkorn D, Creutz C, Hornung WP, Klingmüller D, Lemke MR, Maier W, Schubert M, Sträter B, Kühn KU.

J Sex Med. 2008 Dec;5(12):2816-26. doi: 10.1111/j.1743-6109.2008.00859.x. Epub 2008 May 7.

PMID:
18466271
[PubMed - indexed for MEDLINE]
18.

Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.

Kahn RS, Schulz SC, Palazov VD, Reyes EB, Brecher M, Svensson O, Andersson HM, Meulien D; Study 132 Investigators.

J Clin Psychiatry. 2007 Jun;68(6):832-42.

PMID:
17592906
[PubMed - indexed for MEDLINE]
19.

A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.

Honer WG, MacEwan GW, Gendron A, Stip E, Labelle A, Williams R, Eriksson H; STACK Study Group.

J Clin Psychiatry. 2012 Jan;73(1):13-20. doi: 10.4088/JCP.10m06194. Epub 2011 Jun 14.

PMID:
21733490
[PubMed - indexed for MEDLINE]
20.

Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?

Citrome L.

Clin Schizophr Relat Psychoses. 2012 Jul;6(2):76-85. doi: 10.3371/CSRP.6.2.5.

PMID:
22776634
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk